SMITH ASSET MANAGEMENT GROUP LP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 184 filers reported holding TG THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$5,000
-16.7%
1200.0%0.00%
Q1 2021$6,000
-96.7%
120
-96.6%
0.00%
-100.0%
Q4 2020$183,000
+94.7%
3,510
-0.3%
0.01%
+120.0%
Q3 2020$94,000
-87.8%
3,520
-95.7%
0.01%
-82.1%
Q2 2014$770,000
-42.7%
81,989
-57.9%
0.03%
-45.1%
Q1 2014$1,343,000
+75.1%
194,701
-1.0%
0.05%
+75.9%
Q4 2013$767,000196,6840.03%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders